drugset / Trial / NCT00360698

Insulin Glulisine in Type 2 Diabetic Patients

NCT00360698

Phase 4 Completed 106 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of a single injection of glulisine before the main meal added to insulin glargine plus oral antidiabetic drugs (OADs) compared to insulin glargine plus OADs in Type 2 diabetic patients poorly controlled with basal insulin plus OADs.

Timeline

Start
2006-07
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin glulisine Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic
Background Glimepiride Small molecule
Background Metformin Small molecule